Transient global or forebrain ischemia leads to severe brain damage following delayed neuronal cell death. We previously reported that cyclosporin A (CsA) provides near total suppression of brain damage in rat forebrain ischemia when allowed to pass the blood brain barrier, whereas Tacrolimus (FK506) is considerably less effective. We demonstrate herein that when administered prior to ischemic insult, both immunosuppressants equally block calcineurin, a type 2B Ser/Thr phosphatase, and efficiently inhibit dephosphorylation of pro-apoptotic protein Bad. CsA demonstrates more potent anti-ischemic effects than FK506, partially attributable to amelioration of mitochondrial damage as assayed in vivo and in vitro. These results suggest that pathways including calcineurin and cyclophilins, particularly mitochondrial cyclophilin D, play pivotal roles in ischemic brain damage. Since previous results have shown that CsA is efficacious also when administered after focal ischemia, the present findings give hints to clinical applications for new drugs for the treatment of ischemic damage in the brain as well as in the heart and liver. © 2002 Elsevier Science (USA)
INTRODUCTION
Strokes caused by global and focal ischemia present major medical, social, and economic problems throughout the world. Transient global ischemia leads to severe brain damage in selectively vulnerable regions, such as the CA1 sector of the hippocampus, the medium-sized neurons in caudate-putamen, and the neocortical neurons in layers 3-5 (Kirino, 1982; Pulsinelli, et al., 1982) . Neuroprotective effects of immunosuppressants on ischemic brain damage was first reported for Tacrolimus (FK506) in rats with focal ischemia (Sharkey and Butcher, 1994) . Pretreatment with cyclosporin A (CsA) also reduces forebrain ischemic damage in rats, provided that the drug is allowed to penetrate the blood-brain barrier (BBB) (Uchino et al., 1995; 1998; Siesjö et al., 1999) . Although no direct comparison has been made, the effects of FK506 in this model of ischemia seems less pronounced than those of CsA (Drake, et al., 1996) .
